Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

What I am saying is - with competitors having one dose treatments for ABSSSI -- Oratavancin - already - Dalbavancin, soon - B does not have one day unique advantage - also we are at least 1 year time for B advantage

So the big pharma will have much less incentive - the product will still be successful but may not fetch as much money for CTIX. (The Medicine co still does not have any buyer for their drug and they have to market it and it is not doing that good)